Lewis R. Vidler
Eli Lilly (United States)(US)Eli Lilly (United Kingdom)(GB)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Crystallization and Solubility Studies, Protein Degradation and Inhibitors, X-ray Diffraction in Crystallography, Chemical Synthesis and Analysis
Most-Cited Works
- → Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites(2012)272 cited
- → Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening(2013)126 cited
- → Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B(2015)101 cited
- → Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency – molecular profiling and functional rescue(2017)93 cited
- → Changing the local coordination environment in mono- and bi- nuclear lanthanide complexes through “click” chemistry(2009)75 cited
- → Machine Learning for Toxicity Prediction Using Chemical Structures: Pillars for Success in the Real World(2025)62 cited
- → Design and Synthesis of 56 Shape‐Diverse 3D Fragments(2020)60 cited
- → Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia(2016)34 cited
- → Investigating the Behavior of Published PAINS Alerts Using a Pharmaceutical Company Data Set(2018)31 cited
- → Creating a Virtual Assistant for Medicinal Chemistry(2019)15 cited